| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | -16.19% | +0.71% | -16.90% | -16.90% | — |
| 14d | 2 | +50.00% | -8.96% | +4.98% | -13.95% | -13.95% | — |
| 30d | 2 | +100.00% | +21.62% | +10.51% | +11.12% | +11.12% | — |
| 60d | 2 | +50.00% | +11.53% | +5.00% | -26.07% | -26.07% | — |
| 90d | 2(1 pending) | +100.00% | +48.65% | +12.09% | +36.55% | +36.55% | — |
| 180d | 2(2 pending) | — | — | — | — | — | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| NSRX NASUS PHARMA LTD | PURCHASE Chief Executive Officer | 6,550 | $3.10 | $20.3K | 163,541 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| NSRX NASUS PHARMA LTD | PURCHASE Chief Executive Officer | 2,900 | $3.76 | $10.9K | 156,991 | Apr 22, 2026 | Apr 22, 2026 ↗ | View → |
| NSRX NASUS PHARMA LTD | PURCHASE Chief Executive Officer | 15,000 | $2.04 | $30.6K | 21,246 | Mar 31, 2026 | Apr 1, 2026 ↗ | View → |